The global aesthetic medicine market size is expected to reach USD 332.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.5% from 2022 to 2030. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is a branch of medicine focused on satisfying the aesthetic desires and goals of patients. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Some key drivers of the market include the introduction of innovative aesthetic devices such as non-invasive aesthetic devices, a growing focus on physical appearance, and a rise in adoption among geriatric individuals.
Aesthetic Medicine Market Segmentation
Grand View Research has segmented the global aesthetic medicine market report on the basis of procedure type and region:
Based on the Procedure Type Insights, the market is segmented into invasive procedures, non-invasive procedures.
- The non-invasive procedures segment dominated the market in 2021 with a share of over 50.0%. The segment is also expected to expand at the fastest CAGR over the forecast period.
- Less pain, instant results, and low cost are some of the factors that have boosted the demand for non-invasive procedures at a global level. Popular non-invasive procedures include Botox injections, soft tissue fillers, and chemical peels.
- The product is found to be effective in reducing wrinkles. Invasive procedures such as liposuction, breast augmentation, and nose reshaping are some of the popular aesthetic procedures. Growing focus on physical appearance has increased the demand for these invasive procedures.
Aesthetic Medicine Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
The market for aesthetic medicine is highly fragmented with many local players competing with international players. However, a strict regulatory approval process is challenging the entry of new products into the market. Primary parameters affecting the competition are the rapid adoption of advanced devices for improved treatment and technological advancement.
Some prominent players in the global aesthetic medicine market include:
- AbbVie
- Cynosure
- Evolus Inc.
- Revance Galderma
- Lumenis
- Solta Medical
- Syneron Candela
- Alma Laser
Market Industry Development
- June 2020: Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), received FDA approval of JUVÉDERM® VOLUMA™ XC for the augmentation of the chin region in adults over the age of 21
- In 2019: The FDA approved Jeuveau, which is similar to Botox, however, is available at a lower cost compared to Botox.
Order a free sample PDF of the Aesthetic Medicine Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment